Gyrodyne
GYRO
14 hedge funds and large institutions have $10.3M invested in Gyrodyne in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
12% more capital invested
Capital invested by funds: $9.14M → $10.3M (+$1.14M)
8% more funds holding
Funds holding: 13 → 14 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.56% less ownership
Funds ownership: 33.82% → 33.26% (-0.56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$171K |
| 2 |
TA
Teton Advisors
Rye,
New York
|
+$11.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$6.08K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.95K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$133K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
| $2.39M | -$133K | -6,800 | -6% |
|
|
TL
2
TowerView LLC
New York
| $2.14M | – | – | – |
|
|
GCIA
3
Gabelli & Co Investment Advisers
Rye,
New York
| $1.82M | – | – | – |
|
|
MFP
4
Michael F. Price
| $1.77M | – | – | – |
|
|
CL
5
CSS LLC
Chicago,
Illinois
| $901K | – | – | – |
|
|
GF
6
Gabelli Funds
Rye,
New York
| $629K | – | – | – |
|
|
TA
7
Teton Advisors
Rye,
New York
| $262K | +$11.8K | +607 | +5% |
|
|
8
BlackRock
New York
| $182K | +$171K | +8,763 | New |
|
|
BBPWM
9
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| $152K | – | – | – |
|
10
Morgan Stanley
New York
| $16K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $6K | +$6.08K | +312 | New |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $2K | +$1.95K | +100 | New |
|
14
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1K | – | – | – |
|
GYRO Hedge Fund Activity: Q1 2017 in Review
14 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Gyrodyne (GYRO) for Q1 2017, worth a combined $10.3M — up 12% from $9.14M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GYRO positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $171K. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $133K.
- 14 institutional investors held Gyrodyne (GYRO) as of Q1 2017, up from 13 in Q4 2016.
- Funds reported $10.3M of Gyrodyne stock for Q1 2017, up 12% quarter-over-quarter.
- 3 funds opened new Gyrodyne positions in Q1 2017 and 0 closed out, a net change of +3 holders.
- The largest Gyrodyne buyer in Q1 2017 was BlackRock, an estimated $171K added.
- The largest Gyrodyne seller in Q1 2017 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $133K sold.
Based on aggregated 13F filings for Q1 2017.